SFI
FENC icon

Sonic Fund II’s Fennec Pharmaceuticals FENC Stock Holding History

Sonic Fund II’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,407,357
Closed -$19.5M – 9
2022
Q3 		$19.5M Hold
2,407,357
– – 13.24% 1
2022
Q2 		$13.4M Hold
2,407,357
– – 8.2% 3
2022
Q1 		$13.5M Hold
2,407,357
– – 7.57% 2
2021
Q4 		$10.6M Hold
2,407,357
– – 6.86% 4
2021
Q3 		$22.7M Sell
2,407,357
-25,873
-1% -$194K 12.81% 1
2021
Q2 		$17.7M Hold
2,433,230
– – 8.09% 2
2021
Q1 		$15.1M Hold
2,433,230
– – 6.24% 4
2020
Q4 		$18.1M Buy
2,433,230
+798,541
+49% +$6.08M 8.76% 3
2020
Q3 		$9.91M Hold
1,634,689
– – 6.96% 3
2020
Q2 		$13.7M Buy
1,634,689
+800,000
+96% +$5.95M 6.79% 5
2020
Q1 		$4.96M Hold
834,689
– – 4.3% 8
2019
Q4 		$5.42M Buy
+834,689
New +$4.48M 5.56% 5

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Sonic Fund II's FENC Position: Q4 2022 in Review

Sonic Fund II sold out of Fennec Pharmaceuticals (FENC) in Q4 2022, closing a stake of 2,407,357 shares — an estimated $19.5M sold.

Sonic Fund II first reported a position in FENC in Q4 2019 and held it in 12 quarters. The position peaked at $22.7M in Q3 2021. 43 funds tracked by Wall St. Rank hold FENC as of Q4 2022.

  • Sonic Fund II reported no remaining Fennec Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Sonic Fund II sold 2,407,357 Fennec Pharmaceuticals shares in Q4 2022, an estimated $19.5M.
  • Sonic Fund II first reported a position in Fennec Pharmaceuticals in Q4 2019 and held it in 12 quarters.
  • Sonic Fund II's Fennec Pharmaceuticals position peaked at $22.7M in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2022.

Based on Sonic Fund II's 13F filing for Q4 2022.